12 Best Dow Stocks To Buy Right Now

Published on April 4, 2023 at 6:21 am by Swati Goyal in Hedge Funds, News

In this article, we will take a look at 12 best Dow stocks to buy right now. If you want to see some more of the best Dow stocks to buy, go directly to the 5 Best Dow Stocks To Buy Right Now.

The Dow Jones Industrial Average (DJIA) is a widely recognized stock market index comprised of 30 large publicly traded companies in the U.S., including Apple, Coca-Cola, and JPMorgan Chase & Co. These companies are industry leaders and reliable indicators of the U.S. stock market’s overall health.

The DJIA is a price-weighted index that uses a single share price of companies on the index, adjusted for stock splits and dividends. As a result, long-term investors should diversify their portfolios across different stocks and sectors and consider top Dow stocks like Johnson & Johnson (NYSE:JNJ), Merck & Co Inc. (NYSE:MRK), and Walmart Inc. (NYSE:WMT). The Dow Jones finished January 2023 up 2.8%, while the Nasdaq and S&P 500 gained 10.7% and 6.2%, respectively, as the market continued to rebound from mid-October lows.

The Dow Jones Industrial Average tends to have better average returns in March compared to February and is in the middle of the pack compared to other months, with a positive return 58% of the time in the last century, 64% in the last 50 years, and 65% over the previous 20 years.

In March 2023, the S&P 500 gained 3.51%, the Nasdaq gained 6.69%, and the Dow gained 1.89%. The month was marked by volatility due to the failure of two regional banks, a forced takeover of Credit Suisse, and deposit flight from smaller institutions.

April historically has been the top month for returns in the Dow Jones Industrial Average, with gains of 1.9% going back to 1950. April historically has been a good month for the stock market, attributed to the end of tax season and optimism for second-quarter earnings.

Dow stocks are seen as a safe haven amidst rising interest rates, high inflation, and a gloomy GDP forecast. They are favored by hedge funds and billionaire investors. Investors looking to buy the best Dow stocks right now may consider companies that have shown consistent growth over the past few years, as well as those that have a strong financial position and a promising future outlook.

Our Methodology

We scanned the 30 stocks in the Dow index and picked 12 stocks with highest number of hedge fund investors. We gauged hedge fund sentiment around stocks using Insider Monkey’s database of 943 hedge funds and their holdings.

Best Dow Stocks To Buy Right Now

12. American Express Co (NYSE:AXP)

Number of Hedge Fund Holders: 71

American Express Company (NYSE:AXP) offers charge/credit cards and travel services globally. Its stock price rose 79.47% in the last five years, surpassing the S&P 500.

Morgan Stanley’s Betsy Graseck raised American Express Company (NYSE:AXP) to ‘Overweight’ from ‘Equal Weight’ with a target price of $186, naming it as the top pick in consumer finance. The firm favors stocks with high credit quality, sustainable revenue growth, and positive operating leverage.

As of the fourth quarter of 2022, 71 hedge funds in Insider Monkey’s database held stakes in American Express Company (NYSE:AXP). The most prominent shareholder in American Express Company (NYSE:AXP) is Berkshire Hathaway, with 151.6 million shares valued at $22.40 billion.

11. Goldman Sachs Group Inc (NYSE:GS)

Number of Hedge Fund Holders: 74

Goldman Sachs Group (NYSE:GS) provides financial services to various entities globally. Given its expertise in trading and investment banking, G.S. could benefit from the growth of the broader market and increased demand for asset management. At a Forward P/E ratio of 8.95x compared to the industry average of 11.94x, Goldman Sachs Group (NYSE:GS) offers a potential investment opportunity.

Goldman Sachs Group (NYSE:GS) has a ‘Moderate Buy’ consensus rating with 11 buy ratings, 6 hold ratings, and no sell ratings. Based on the Wall Street analysts’ 12-month price targets issued, the average price target is $407.26, indicating a potential 24.50% increase from the current price of $327.11. The highest price target is $495.00, and the lowest is $332.00.

At the end of the fourth quarter of 2022, 74 hedge funds in the database of Insider Monkey held stakes worth $4.90 billion in Goldman Sachs Group (NYSE:GS), up from 69 in the preceding quarter worth $4.57 billion. Boykin Curry’s Eagle Capital Management, with 3.27 million shares, is the biggest stakeholder in the company.

In its Q3 2022 investor letter, Manole Capital Management stated the following about the Goldman Sachs Group Inc (NYSE:GS):

“Back in 2019, The Goldman Sachs Group, Inc. (NYSE:GS) made a splash in the card industry by working with Apple and MasterCard on a credit card. The actual card is fairly sleek (as you can see below), as customers names are etched into an Apple titanium card. The no-fee card generated a lot of hype, as many early users were quick to post their latest card on various social media sites….” (Click here to read the full text)

10. The Procter & Gamble Company (NYSE:PG)

Number of Hedge Fund Holders: 74

The Procter & Gamble Company (NYSE:PG) sells everyday necessities with leading market shares, such as razors, with over 60% of the global market.

The Procter & Gamble Company (NYSE:PG) has a ‘Strong Buy’ consensus rating with an average price target of $157.38, representing a 5.84% increase from the current price of $148.69. The price targets range from $141.00 to $170.00, based on 12 buy and 4 hold ratings.

Hedge funds tracked by Insider Monkey having stakes in The Procter & Gamble Company (NYSE:PG) increased to 74 in Q4 from 69 in the preceding quarter. These stakes hold a consolidated value of $4.72 billion. Bridgewater Associates is a significant shareholder in the company, with 4.99 million shares valued at $757.14 million.

In its Q4 2022 investor letter, Rowan Street Capital cited The Procter & Gamble Company (NYSE:PG). Here is what the fund said:

“Let’s look at The Procter & Gamble Company (NYSE: P.G.). Dividend yield is 2.4%. Earnings are forecasted to grow at 5.9%, and its current earnings multiple is at 25x. Now, let’s say over the next 3-5 years the market loses interest in the “safe”, mature companies that grow at anemic rates and gets an appetite for growth again. It’s very unlikely that Mr. Market will be paying 25x for 5.9% earnings growth. Lets assume that multiple declines to the market average of 18x — that would be ~6.9% drag per year on the total expected return over next 3-5 years. If we get 2.4% (dividend) + 5.9% (earnings growth) – 6.9% (decrease in earnings multiple) = 1.4% (annual return we can expect on average from this stock).”

9. Merck & Co Inc. (NYSE:MRK)

Number of Hedge Fund Holders: 77

Merck & Co Inc. (NYSE:MRK) is one of the top global drug manufacturers, with a market cap of $270.08 billion as of April 3. Its product portfolio includes Keytruda, Gardasil, Lagevrio, Januvia/Janumet, Proquad, Bridion, and Lynparza.

Merck & Co Inc. (NYSE:MRK) is rated as ‘Moderate Buy’ with an average price target of $119.20, indicating a 12.04% increase from the current price of $106.39. The highest analyst price target is $130.00, and the lowest forecast is $96.00. There are 14 buy ratings and 7 hold ratings for the stock.

At the end of Q4, 77 hedge funds were long Merck & Co Inc. (NYSE:MRK), compared to 82 funds in the prior quarter. Among these hedge funds, AQR Capital Management is Merck & Co Inc. (NYSE:MRK)’s most noticeable stakeholder, with 3.11 million shares worth $344.9 million.

In its Q4 2022 investor letter, Aristotle Capital Management, LLC stated the following about Merck & Co Inc. (NYSE:MRK):

“Founded in 1891 and headquartered in New Jersey, Merck & Co., Inc. (NYSE:MRK) is one the world’s largest pharmaceutical firms. The company’s drugs are used to treat conditions in a variety of areas, including oncology (~38% of revenue), vaccines (~19%), diabetes (~11%), animal health (~11%) and other (~21%). Merck produced over $48 billion in sales in 2021, just under half of which were generated in the United States. Within oncology, the firm’s immuno-oncology platform is becoming a major contributor to overall sales, driven by the blockbuster1 drug Keytruda. The company’s vaccine business is also significant and includes Gardasil for the prevention of HPV (the disease that can lead to cervical cancer in women), as well as vaccines for hepatitis B, pediatric diseases and shingles. In recent years, Merck has been shifting its focus toward unmet medical needs in specialty-care areas. As part of this shift in focus, in June 2021, Merck received $9 billion from the spinoff of its women’s health, established brands, and biosimilars businesses into the now independent, publicly traded company Organon…” (Click here to read the full text)

8. Johnson & Johnson (NYSE:JNJ)

Number of Hedge Fund Holders: 84

Johnson & Johnson (NYSE:JNJ) is a global healthcare company that develops, manufactures, and sells various products.

On March 29, UBS initiated coverage of Johnson & Johnson (NYSE:JNJ) with a ‘Neutral’ rating and a $164 price target in a U.S. Medical Supplies and Devices sector note. The firm believes the company’s 2023 and 2024 EPS and sales estimates are conservative but has low visibility into the near-term sales outlook due to STELARA LOE, which puts approximately 10% of sales at risk starting late 2023.

In the fourth quarter of 2022, 84 hedge funds monitored by Insider Monkey reported holding stakes in Johnson & Johnson (NYSE:JNJ). The total value of these holdings is around $5.57 billion. Johnson & Johnson (NYSE:JNJ) stands eighth on the list of 12 best Dow stocks to buy right now. With 3.57 million shares worth $630.27 million, Ray Dalio’s Bridgewater Associates is Johnson & Johnson (NYSE:JNJ)’s notable stakeholder in Q4 2022.

7. The Walt Disney Company (NYSE:DIS)

Number of Hedge Fund Holders: 99

The Walt Disney Company (NYSE:DIS), a global entertainment company, experienced operating losses in its streaming services last year, resulting in a 27.75% drop in shares. With the return of former CEO Bob Iger, cost-saving measures have been implemented, and the company plans to improve the guest experience in its parks, experiences, and products unit. Focusing on core brands and franchises like Star Wars, Avatar and the Marvel Cinematic Universe has driven engagement and sales. Despite pandemic effects, Disney’s restructuring and cost-saving program are expected to make it more efficient and profitable in the future. Disney stock has risen 3.09% in the past six months, making it a good long-term investment.

The Walt Disney Company (NYSE:DIS) is a ‘Strong Buy’ with 17 buy ratings and an average price target of $128.41, representing a 28.24% increase from the current price of $100.13. The highest price target is $141.00, and the lowest is $110.00.

According to Insider Monkey’s data, The Walt Disney Company (NYSE:DIS) was part of 99 hedge fund portfolios at the end of Q4 2022, compared to 112 in the Q3 2022. Trian Partners is the biggest stakeholder of The Walt Disney Company (NYSE:DIS), with 9.03 million shares worth $784.51 million.

Meridian Funds made the following comment about The Walt Disney Company (NYSE:DIS) in its Q4 2022 investor letter:

“Global entertainment giant The Walt Disney Company (NYSE:DIS) lagged the market as results in its theme park business missed expectations, due in part to recession-wary consumers and the continued pandemic-related shutdown of its resort in Shanghai. In addition, investor uncertainty around the long-term profitability of its streaming business continued, although Disney rolled out price increases and an advertising-supported tier of its Disney+ subscription service during the quarter. The company also changed its leadership, bringing former CEO Bob Iger back to the top job. While disappointed with the stock’s recent performance, we intend to stay patient as the company’s broad reservoir of iconic brands and related franchises provide multiple avenues for long-term value creation. In our view, the broader market continues to underestimate Disney’s franchise value and its earnings power.”

6. JPMorgan Chase & Co (NYSE:JPM)

Number of Hedge Fund Holders: 100

JPMorgan Chase & Co (NYSE:JPM) benefits from consolidation in the U.S. banking sector as it scoops up customers leaving Silicon Valley Bank and other small banks. The company’s stock is a good value, with a P/E ratio of 9.78x. It also pays an annual dividend yield of 3.07%. JPMorgan Chase & Co (NYSE:JPM) is likely to emerge as one of the strongest banking plays on the market, and its position as the largest bank in the U.S. was highlighted when it deposited billions into First Republic Bank (NYSE:FRC).

JPMorgan Chase & Co (NYSE:JPM) is currently rated as a ‘Moderate Buy’ by analysts, with 11 buy ratings and 4 hold ratings. The average price target for the stock is $153.73, with a high target of $189.00 and a low of $120.00. This suggests a potential increase of 17.97% from the current price of $130.31.

Hedge fund interest in JPMorgan Chase & Co (NYSE:JPM) has lately decreased. JPMorgan Chase & Co (NYSE:JPM) was in 100 hedge funds’ portfolios at the end of the fourth quarter of 2022, down from 110 funds a quarter earlier. Greenhaven Associates, with 4.80 million shares, is the biggest stakeholder in the company.

Along with Johnson & Johnson (NYSE:JNJ), Merck & Co Inc. (NYSE:MRK), and Walmart Inc. (NYSE:WMT), JPMorgan Chase & Co (NYSE:JPM) is one of the Dow stocks on the radar of the investors.

In its Q3 2022 investor letter, Vltava Fund stated the following about JPMorgan Chase & Co. (NYSE:JPM):

“We regard JPM to be the strongest and best- managed bank in the world. It is a leader in investment banking, commercial banking, credit cards, and asset management. Its size (the largest bank in the USA, with nearly USD 4,000 billion in assets) and diversification give it a strong competitive advantage that is compounded by its cost advantages and the high costs to clients associated with switching banks. JPM’s management prides itself on running the only large bank to avoid major instability over the long term.

JP Morgan’s quality and strength first became fully evident in 2008 under the leadership of its CEO Jamie Dimon. Not only did JP Morgan help to stabilize the market by taking over the failing Bear Stearns in the spring of that year, but throughout the Great Financial Crisis it was the only big U.S. bank that did not require government assistance and it was highly profitable even in the difficult year of 2008.

A well-functioning and efficient bank can be a very good long-term investment, because the interest compounding effect works well here. JPM’s return on equity (ROE) is well into the double digits and this puts it in a good position to continue producing better long-term returns than does the market. JPM has been very profitable even during years when interest rates were close to zero. The current – and perhaps not temporary – return to somewhat more normal, higher interest rates should have a significantly positive impact on the bank’s interest income and overall profitability.”

Click to continue reading and see 5 Best Dow Stocks To Buy Right Now.

AI Fire Sale: Insider Monkey’s #1 AI Stock Pick Is On A Steep Discount

Published on May 1, 2024 at by Inan Dogan, PhD

Artificial intelligence is the greatest investment opportunity of our lifetime. The time to invest in groundbreaking AI is now, and this stock is a steal!

The whispers are turning into roars.

Artificial intelligence isn’t science fiction anymore.

It’s the revolution reshaping every industry on the planet.

From driverless cars to medical breakthroughs, AI is on the cusp of a global explosion, and savvy investors stand to reap the rewards.

Here’s why this is the prime moment to jump on the AI bandwagon:

Exponential Growth on the Horizon: Forget linear growth – AI is poised for a hockey stick trajectory.

Imagine every sector, from healthcare to finance, infused with superhuman intelligence.

We’re talking disease prediction, hyper-personalized marketing, and automated logistics that streamline everything.

This isn’t a maybe – it’s an inevitability.

Early investors will be the ones positioned to ride the wave of this technological tsunami.

Ground Floor Opportunity: Remember the early days of the internet?

Those who saw the potential of tech giants back then are sitting pretty today.

AI is at a similar inflection point.

We’re not talking about established players – we’re talking about nimble startups with groundbreaking ideas and the potential to become the next Google or Amazon.

This is your chance to get in before the rockets take off!

Disruption is the New Name of the Game: Let’s face it, complacency breeds stagnation.

AI is the ultimate disruptor, and it’s shaking the foundations of traditional industries.

The companies that embrace AI will thrive, while the dinosaurs clinging to outdated methods will be left in the dust.

As an investor, you want to be on the side of the winners, and AI is the winning ticket.

The Talent Pool is Overflowing: The world’s brightest minds are flocking to AI.

From computer scientists to mathematicians, the next generation of innovators is pouring its energy into this field.

This influx of talent guarantees a constant stream of groundbreaking ideas and rapid advancements.

By investing in AI, you’re essentially backing the future.

The future is powered by artificial intelligence, and the time to invest is NOW.

Don’t be a spectator in this technological revolution.

Dive into the AI gold rush and watch your portfolio soar alongside the brightest minds of our generation.

This isn’t just about making money – it’s about being part of the future.

So, buckle up and get ready for the ride of your investment life!

Act Now and Unlock a Potential 10,000% Return: This AI Stock is a Diamond in the Rough (But Our Help is Key!)

The AI revolution is upon us, and savvy investors stand to make a fortune.

But with so many choices, how do you find the hidden gem – the company poised for explosive growth?

That’s where our expertise comes in.

We’ve got the answer, but there’s a twist…

Imagine an AI company so groundbreaking, so far ahead of the curve, that even if its stock price quadrupled today, it would still be considered ridiculously cheap.

That’s the potential you’re looking at. This isn’t just about a decent return – we’re talking about a 10,000% gain over the next decade!

Our research team has identified a hidden gem – an AI company with cutting-edge technology, massive potential, and a current stock price that screams opportunity.

This company boasts the most advanced technology in the AI sector, putting them leagues ahead of competitors.

It’s like having a race car on a go-kart track.

They have a strong possibility of cornering entire markets, becoming the undisputed leader in their field.

Here’s the catch (it’s a good one): To uncover this sleeping giant, you’ll need our exclusive intel.

We want to make sure none of our valued readers miss out on this groundbreaking opportunity!

That’s why we’re slashing the price of our Premium Readership Newsletter by a whopping 75%.

For a ridiculously low price of just $24, you can unlock a year’s worth of in-depth investment research and exclusive insights – that’s less than a single restaurant meal!

Here’s why this is a deal you can’t afford to pass up:

The Name of the Game-Changing AI Stock: Our in-depth report dives deep into our #1 AI stock’s groundbreaking technology and massive growth potential.
Ad-Free Browsing: Enjoy a year of investment research free from distracting banner and pop-up ads, allowing you to focus on uncovering the next big opportunity.
Lifetime Money-Back Guarantee: If you’re not absolutely satisfied with our service, we’ll provide a full refund ANYTIME, no questions asked.

Space is Limited! Only 1000 spots are available for this exclusive offer. Don’t let this chance slip away – subscribe to our Premium Readership Newsletter today and unlock the potential for a life-changing investment.

Here’s what to do next:

Head over to our website and subscribe to our Premium Readership Newsletter for just $24.
Enjoy a year of ad-free browsing, exclusive access to our in-depth report on the revolutionary AI company, and the upcoming issues of our Premium Readership Newsletter over the next 12 months.
Sit back, relax, and know that you’re backed by our ironclad lifetime money-back guarantee.

Don’t miss out on this incredible opportunity! Subscribe now and take control of your AI investment future!

Subscribe Now!

A New Dawn is Coming to U.S. Stocks

Published on May 2, 2024 at by Insider Monkey Staff

I work for one of the largest independent financial publishers in the world – representing over 1 million people in 148 countries.

We’re independently funding today’s broadcast to address something on the mind of every investor in America right now…

Should I put my money in Artificial Intelligence?

Here to answer that for us… and give away his No. 1 free AI recommendation… is 50-year Wall Street titan, Marc Chaikin.

Marc’s been a trader, stockbroker, and analyst. He was the head of the options department at a major brokerage firm and is a sought-after expert for CNBC, Fox Business, Barron’s, and Yahoo! Finance…

But what Marc’s most known for is his award-winning stock-rating system. Which determines whether a stock could shoot sky-high in the next three to six months… or come crashing down.

That’s why Marc’s work appears in every Bloomberg and Reuters terminal on the planet…

And is still used by hundreds of banks, hedge funds, and brokerages to track the billions of dollars flowing in and out of stocks each day.

He’s used this system to survive nine bear markets… create three new indices for the Nasdaq… and even predict the brutal bear market of 2022, 90 days in advance.

Click to continue reading…

Insider Monkey Ads

Markets

Insider Trading

Hedge Funds

Retirement

Opinion

Log In

Sign Up